Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

NCT00104130 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
53
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb